rabbit polyclonal antibody directed against the human runx2 (Santa Cruz Biotechnology)
Structured Review

Rabbit Polyclonal Antibody Directed Against The Human Runx2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibodies+against+runx2/pmc11138106-440-7-9?v=Santa+Cruz+Biotechnology
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Whole-genome sequencing uncovers two loci for coronary artery calcification and identifies ARSE as a regulator of vascular calcification"
Article Title: Whole-genome sequencing uncovers two loci for coronary artery calcification and identifies ARSE as a regulator of vascular calcification
Journal: Nature cardiovascular research
doi: 10.1038/s44161-023-00375-y
Figure Legend Snippet: a) Treatment of human coronary artery vascular smooth muscle cells (n = 6 biologically independent samples in each group) with osteogenic media decreased MMP16 mRNA expression by ~74% (left panel). Treatment of cells grown in osteogenic media with siMMP16 (resulting in >90% knockdown of MMP16 mRNA) had no effect on RUNX2 (middle panel) or CNN1 (right panel) mRNA levels. Statistical comparisons were made using a two-tailed one-way ANOVA with Sidak’s post-hoc comparison testing. The mean ± SEM is depicted in plots. b) Treatment of human coronary artery vascular smooth muscle cells grown in osteogenic media with siMMP16 had no effect on calcification, as evidenced by decreased Alizarin Red S staining.
Techniques Used: Expressing, Knockdown, Two Tailed Test, Comparison, Staining
Figure Legend Snippet: a) Cross sections of human coronary arteries from control subjects and patients with ischemic coronary artery disease (n=3 individuals in each group with 2 sections stained for each individual) were stained for ARSE (red), α-smooth muscle actin (green) and DNA (blue, DAPI). Immunofluorescence analysis shows a higher expression of ARSE in diseased arteries. Alizarin red staining for calcification was high in the coronary arteries of diseased patients with no significant stain observed in the control group. Scale bars, 200 µm for each immunofluorescence image; 500 µm for each Alizarin red staining image. Statistical comparisons were made using a two-tailed Student’s t test. The mean is depicted in plots, with the error bars representing the standard error of the mean. b) Cross sections of human coronary arteries (n=1 each for control and ischemic patient) were stained for ARSE (red), RUNX2 (green, VSMC calcification marker) and DNA (blue, DAPI). Immunofluorescence analysis shows a higher expression of ARSE in calcified diseased arteries that colocalized with increased RUNX2 expression. Scale bar 500 µm.
Techniques Used: Expressing, Control, Staining, Immunofluorescence, Two Tailed Test, Marker
Figure Legend Snippet: a) Treatment of human coronary artery vascular smooth muscle cells (n = 6 biologically independent samples in each group) with osteogenic media for 3 days increased ARSE mRNA expression approximately 5-fold. Treatment of cells grown in osteogenic media with siARSE resulted in >90% knockdown of ARSE mRNA. b) Protein expression of ARSE was measured by immunoblot (left panel) using antibodies directed against ARSE and GAPDH (for a loading control). Treatment of cells with osteogenic media increased ARSE protein levels by 1.5-fold (right panel). Treatment of cells grown in osteogenic media with siARSE resulted in >70% reduction of ARSE protein (n=4 biologically independent samples in each group). c) Treatment of cells grown in osteogenic media with siARSE ameliorated osteogenic phenotype switch as evidenced by decreased RUNX2, BGLAP, and ALPL mRNA levels, and increased CNN1 mRNA levels ~2-fold. Of note, silencing ARSE in cells grown in normal media increased CNN1 mRNA levels by > 5-fold (n=6 biologically independent samples in each group except n=5 for siARSE CNN1 data). d) Reduced ARSE expression was also associated with an approximately 50% decrease in RUNX2 and >30% increase in CNN1 protein levels assessed by immunoblot using antibodies directed against RUNX2, CNN1 and VCL (for a loading control) (n=6 biologically independent samples in each group). e) Treatment of cells grown in osteogenic media with siARSE reduced calcification by approximately 60% (right panel, n = 3 biologically independent samples in each group), as evidenced by decreased Alizarin Red staining (left panel). f) Reduced ARSE expression with siARSE treatment in human coronary artery vascular smooth muscle cells grown in collagen discs (left panel) resulted in a >3-fold increase in contraction (right panel, n=6 biologically independent samples in each group). Statistical comparisons were made using either a two-tailed one-way ANOVA with Sidak’s post-hoc comparison testing (for more than two groups) or a two-tailed Student t test (for two groups). The mean is depicted in plots, with the error bars representing the mean ± the standard error of the mean.
Techniques Used: Expressing, Knockdown, Western Blot, Control, Staining, Two Tailed Test, Comparison
Figure Legend Snippet: a) Adenoviral expression of ARSE in human coronary artery vascular smooth muscle cells was associated with an 8-fold increase in RUNX2 protein levels and an approximately 70% decrease in CNN1 protein levels, when cells were harvested 5 days after viral transduction (n=3 biologically independent samples in each group). Protein expression was determined by immunoblot (left panel) using antibodies directed against ARSE, RUNX2, CNN1 and GAPDH (for a loading control) with quantification shown in the right panel. b) As shown by Alizarin Red staining (left panel), increased ARSE expression resulted in augmented calcification in human coronary artery vascular smooth muscle cells (right panel, n = 3 biologically independent samples in each group). Two independent experiments were performed with representative images shown. c) Increased ARSE expression also caused a >70% decrease (right panel, n=6 biologically independent samples in each group) in contraction of human coronary artery vascular smooth muscle cells grown in collagen discs (left panel). Statistical comparisons were made using a two-tailed Student t test. The mean is depicted in plots, with the error bars representing the mean ± the standard error of the mean.
Techniques Used: Expressing, Transduction, Western Blot, Control, Staining, Two Tailed Test
Figure Legend Snippet: a) Treatment of human aortic vascular smooth muscle cells (n = 12 biologically independent samples in each group) with osteogenic media increased ARSE mRNA expression > 2-fold. b) Treatment of cells grown in osteogenic media with siARSE (resulting in >90% knockdown of ARSE mRNA) decreased RUNX2 (left panel), and BGLAP (middle panel) mRNA levels by ~20% and ~43% respectively, and increased CNN1 mRNA levels by > 150% (right panel). Silencing ARSE in cells grown in normal media increased CNN1 mRNA levels by > 2.5-fold. c) Treatment of cells grown in osteogenic media with siARSE reduced calcification, as evidenced by decreased Alizarin Red S staining (n=5 biologically independent samples in each group). d) Reduced ARSE expression in cells grown in collagen discs (left panel) resulted in a >3-fold increase in contraction (right panel, n=6 biologically independent samples in each group). e) Protein expression of ARSE, RUNX2 and CNN1 were confirmed by Western blot using antibodies directed against ARSE, RUNX2, CNN1 and GAPDH (for a loading control). Adenoviral expression of the 70-kDa isoform of ARSE in human aortic vascular smooth muscle cells was associated with a >15-fold increase in RUNX2 protein levels and an approximately 34% decrease in CNN1 protein levels, when cells were harvested 5 days after viral transduction (n=3 biologically independent samples in each group). f) As shown by Alizarin Red staining, increased ARSE expression resulted in augmented calcification in human aortic vascular smooth muscle cells (n=3 biologically independent samples in each group). g) Increased ARSE expression also caused a >70% decrease (right panel, n=6 biologically independent samples in each group) in contraction of human aortic vascular smooth muscle cells grown in collagen discs (left panel). Statistical comparisons were made using either a two-tailed one-way ANOVA with Sidak’s post-hoc comparison testing or a two-tailed Student t test. The mean is depicted in plots, with the error bars representing the standard error of the mean.
Techniques Used: Marker, Expressing, Knockdown, Staining, Western Blot, Control, Transduction, Two Tailed Test, Comparison
Figure Legend Snippet: Atherosclerotic vascular calcification is characterized by the phenotype switch of vascular smooth muscle cells (VSMCs) from a contractile phenotype to a proliferative, osteogenic phenotype. The osteogenic phenotype of VSMCs is characterized by decreased expression of contractile proteins such as calponin (CNN1), but increased expression of Runt-related transcription factor 2 (RUNX2), a master regulator of the phenotype switch, in addition to other markers of calcification such as bone gamma-carboxyglutamate protein (BGLAP) and alkaline phosphatase (ALPL). We identified ARSE as a major regulator of the phenotype switch.
Techniques Used: Expressing



